You are viewing: Australia Structural Heart Devices Market analysis

The Australia Structural Heart Devices Market was valued at $157.9 Million in 2024 and projected to reach to $246.6 Million by 2029, representing a compound annual growth rate of 9.3%. Australia's structural heart devices market is positioned for sustained expansion through 2029, driven by demographic shifts toward an older population with higher incidence of valvular and congenital heart conditions.

Australia Structural Heart Devices Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Australia Structural Heart Devices Market Trends and Insights

  • This expansion reflects Australia's aging population and increasing prevalence of structural heart conditions requiring minimally invasive interventions.
  • Australia's healthcare infrastructure and reimbursement landscape support adoption of advanced cardiac technologies, positioning the country as a key market within the Asia Pacific region. The 9.3% compound annual growth rate in Australia demonstrates strong demand for transcatheter aortic valve replacement (TAVR), mitral valve repair systems, and left atrial appendage (LAA) closure devices.
  • Australia's regulatory environment and clinical expertise drive innovation adoption, while growing patient awareness and physician training programs accelerate market penetration.
  • Between 2024 and 2029, Australia is expected to see increased procedural volumes and expanded reimbursement coverage for structural heart interventions..

Key Market Statistics

  • CAGR (2024-2029) 9.3% CAGR
  • Market Size, 2024 ~USD 157.9 Million
  • Forecast, 2029 ~USD 246.6 Million
  • Country Australia

Australia Structural Heart Devices Market Overview

Market Valuation :

Australia's structural heart devices market reached USD 157.9 million in 2024, with strong momentum driven by aging demographics and increased adoption of minimally invasive procedures across major metropolitan centers.

Projected Growth :

The market is forecast to grow at a CAGR of 9.3% through 2029, reaching USD 246.6 million, outpacing global growth rates and reflecting Australia's advanced healthcare infrastructure and favorable reimbursement policies.

Aging Population Impact :

Australia's rapidly aging population is driving increased prevalence of structural heart conditions, creating sustained demand for innovative transcatheter and surgical interventions in both public and private healthcare settings.

Healthcare Infrastructure :

Australia's robust healthcare system, including Medicare reimbursement support and access to cutting-edge medical facilities, accelerates adoption of advanced structural heart device technologies across major hospitals and cardiac centers.

Australia Structural Heart Devices Market Dynamics

  • The country's well-established healthcare infrastructure, coupled with supportive reimbursement mechanisms through Medicare, creates a favorable environment for device adoption and innovation.
  • Key growth drivers include increasing patient awareness, expanding minimally invasive procedure capabilities, and rising healthcare expenditure.
  • The market will likely see intensified competition among device manufacturers and growing investment in training healthcare professionals on advanced interventional techniques..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • Australia's structural heart devices market will grow from USD 157.9M (2024) to USD 246.6M (2029) at a 9.3% CAGR.
    • Australia's aging demographic and rising structural heart disease prevalence are primary growth catalysts for device adoption.
    • Australia's advanced healthcare infrastructure and favorable reimbursement policies accelerate market expansion compared to regional peers.
    • TAVR, mitral repair, and LAA closure devices represent the fastest-growing segments in Australia's structural heart market.

    Structural Heart Devices Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment TAVR/TAVI PROCEDURES (Type)
    Forecast Period 2024-2029
    Growth Rate CAGR of 9.5% from 2024 to 2029
    Largest Segment HOSPITALS (End User)
    Market Size Base Year (Billions) ~USD 16.32 (2024)
    Revenue Forecast (Billions) ~USD 25.69 (2029)
    Segments Covered Procedure, Type, Product, End User, Accessories

    Australia Structural Heart Devices Market Report Segmentation

    5 segment dimensions are covered across the global market.

    By Procedure

    • Repair Procedures
    • Replacement Procedures

    By Type

    • Annuloplasty
    • Biological Valves
    • Catheters
    • Closure Procedures
    • Guidewires
    • Mechanical Valves
    • Other Accessories
    • Savr Procedures
    • Sheaths
    • Surgical Heart Valves
    • Surgical Valves
    • Tavr/Tavi Procedures
    • Teer Procedures
    • Tmvr Procedures
    • Transcatheter Aortic Valve Replacement (Tavr)
    • Transcatheter Heart Valves
    • Transcatheter Mitral Valve Replacement (Tmvr)
    • Valvuloplasty

    By Product

    • Accessories
    • Annuloplasty Rings
    • Heart Valve Devices
    • Occluders, Closure Systems And Delivery Systems
    • Occluders, Closure Systems, And Delivery Systems

    By End User

    • Ambulatory Surgical Centers
    • Ambulatory Surgical Centres
    • Hospitals
    • Other Accessories
    • Other End Users
    • Other End Users (Cath Labs, Cardiac Centers )
    • Other End Users (Cath Labs, Cardiac Centers)
    • Other End Users (Cath Labs, Cardiac Centres)
    • Others End Users

    By Accessories

    • Catheters
    • Guidewires
    • Other Accessories
    • Sheaths

    AUSTRALIA: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    AMBULATORY SURGICAL CENTERS28.931.233.636.2394245.4497.8
    HOSPITALS205.2223241.5261.8283.9308.2334.9364.28.6
    OTHER END USERS (CATH LABS, CARDIAC CENTERS)26.929.532.335.338.642.346.450.99.6
    TOTAL261283.7307.4333.3361.5392.6426.7464.18.6

    Target Audience

    • Medical Device Manufacturers : Manufacturers need Australia-specific market data to develop localized commercialization strategies, understand reimbursement pathways, and identify growth opportunities in this high-value healthcare market.
    • Healthcare Investors & PE Firms : Investment professionals require detailed Australian market metrics and growth forecasts to evaluate portfolio opportunities, assess market attractiveness, and make informed capital allocation decisions in the structural heart sector.
    • Hospital & Cardiac Center Administrators : Healthcare facility leaders need market insights to justify capital expenditures on structural heart device infrastructure, plan procurement strategies, and align service offerings with market demand trends.
    • Market Entry & Strategy Consultants : Consultants advising clients on Australian healthcare expansion require granular market data, growth drivers, and competitive landscape analysis to develop evidence-based market entry and positioning strategies.
    • Regulatory & Compliance Officers : Regulatory professionals need Australia-specific market context and reimbursement information to navigate TGA approval processes, Medicare listing requirements, and ensure compliant market access strategies.

    Reasons to Buy this Report

    • Market-Specific Sizing : Access precise valuation data for Australia's structural heart devices market with detailed 2024 baseline and 2029 forecasts, enabling accurate financial planning and investment decisions tailored to the Australian healthcare landscape.
    • Growth Trajectory Analysis : Understand Australia's 9.3% CAGR performance relative to global 9.5% benchmarks, identifying unique market dynamics and opportunities specific to the Australian region for competitive positioning.
    • Demographic Insights : Leverage detailed analysis of Australia's aging population trends and their direct correlation to structural heart condition prevalence, enabling targeted market entry and product development strategies.
    • Reimbursement & Regulatory Context : Gain comprehensive understanding of Australia's Medicare reimbursement landscape and healthcare infrastructure that directly influence device adoption rates, pricing strategies, and market accessibility.
    • Competitive Intelligence : Identify key market players, distribution channels, and competitive dynamics specific to Australia's structural heart devices sector to inform go-to-market strategies and partnership opportunities.

    Frequently asked questions

    What is the current size of Australia's structural heart devices market?

    Australia's structural heart devices market was valued at USD 157.9 million in 2024 and is expected to reach USD 246.6 million by 2029.

    What is the projected growth rate for Australia's structural heart devices market?

    Australia's structural heart devices market is projected to grow at a compound annual growth rate (CAGR) of 9.3% from 2024 to 2029.

    Which structural heart devices are most in demand in Australia?

    Transcatheter aortic valve replacement (TAVR) systems, mitral valve repair devices, and left atrial appendage (LAA) closure devices are the most in-demand structural heart devices in Australia.

    What factors are driving growth in Australia's structural heart devices market?

    Australia's aging population, increasing prevalence of structural heart conditions, advanced healthcare infrastructure, favorable reimbursement policies, and growing physician expertise are key growth drivers.

    How does Australia's structural heart market compare to the global market?

    Australia's 9.3% CAGR is slightly below the global 9.5% CAGR, reflecting Australia's mature healthcare system and established market penetration relative to emerging markets in the Asia Pacific region.

    RESEARCH METHODOLOGY

    The study involved four major activities to estimate the current size of the Structural heart devices market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to to identify and collect information for the study of Structural heart devices market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    Extensive primary research was conducted after obtaining information regarding the Structural heart devices market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors from business development, marketing, product development/innovation teams, and related key executives from manufacturers; distributors operating in the Structural heart devices market.; and key opinion leaders.

    Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to technology, application, vertical, and region. Stakeholders from the demand side customers/end users who are using infection control products were interviewed to understand the buyer’s perspective on the suppliers, products, and their current usage and the future outlook of their business, which will affect the overall market.

    The following is a breakdown of the primary respondents:

    Structural Heart Devices Market

    Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.

    Note 2: Other primaries include sales managers, marketing managers, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue.

    As of 2023: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=< USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The research methodology used to estimate the size of the Structural heart devices market includes the following details.

    The market sizing of the market was undertaken from the global side.

    Country-level Analysis: The size of the Structural heart devices market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products in the overall Structural heart devices market was obtained from secondary data and validated by primary participants to arrive at the total Structural heart devices market. Primary participants further validated the numbers.

    Geographic market assessment (by region & country): The geographic assessment was done using the following approaches:

    Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

    Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

    At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall Structural heart devices market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

    Global Structural heart dsevices market size : Top-Down and Bottom-Up Approach

    Structural Heart Devices Market

    Data Triangulation

    The market was split into several segments and subsegments after arriving at the overall market size—using the market size estimation processes. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Structural heart devices market.

    Market Definition

    Structural Heart devices are used to treat conditions such as aortic valve disease, mitral valve disease, atrial septal defect, ventricular septal defect, hypertrophic cardiomyopathy, and tricuspid and pulmonic valve disease. Structural heart devices can be used to close holes in the heart, open narrowed heart valves, or replace damaged valves.

    Stakeholders

    • Medical Device Manufacturers
    • Cardiologists
    • Interventional Cardiologist
    • Healthcare institutions (hospitals and outpatient clinics)
    • Distributors and suppliers
    • Research institutes
    • Health insurance payers
    • Market research and consulting firms

    Report Objectives

    • To define, describe, segment, and forecast the global Structural heart devices market by product, procedure, end user, and region.
    • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets1 concerning individual growth trends, prospects, and contributions to the overall Structural heart devices market.
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
    • To forecast the size of the Structural heart devices market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile key players in the global Structural heart devices market and comprehensively analyze their core competencies2 and market shares.
    • To track and analyze competitive developments such as acquisitions, expansions, partnerships, agreements, and collaborations; and product launches and approvals.
    • To benchmark players within the Structural heart devices market using the "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy.

    Get the Full Structural Heart Devices Market Report

    Full forecast, segment splits, and company analysis for all Structural Heart Devices Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status